Data through FY2026 Q3 (Jun 30, 2026)
Horizon Therapeutics USA, Inc.
Company profile for Horizon Therapeutics USA, Inc. covers 54 filings across the reporting window. FY2026 certified median offer: $173,745.
- FY2026 certified median
- $173,745
- Total filings
- 54
- FY2026 25th–75th percentile
- $134,493–$202,832
- Top job title
- Manager, Consumer & Digital Analytics (Rare Disease)
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 28 | $132,193 | $104,840 | $160,000 |
| FY2025 | 19 | $145,001 | $114,781 | $171,213 |
| FY2026 (Q1–Q3) | 7 | $173,745 | $134,493 | $202,832 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Manager, Consumer & Digital Analytics (Rare Disease)3 filings
- Analyst, Commercial Analytics (20516.4488.2)2 filings
- Biostatistics Manager2 filings
- Commercial Insights Manager2 filings
- Commercial Strategy Associate Director2 filings
- Regulatory Affairs Senior Manager2 filings
- Senior Manager, Statistical Programming 20516.4316.52 filings
- Biostatistics Senior Manager1 filings
- Business Intelligence Analyst (20516.4410.3)1 filings
- Business Intelligence Sr. Analyst 20516.43121 filings
Top cities
- Deerfield29 filings
- Rockville5 filings
- South San Francisco4 filings
- Camarillo2 filings
- San Mateo2 filings
- Thousand Oaks2 filings
- Des Plaines2 filings
- Plesanton1 filings
- Redwood City1 filings
- Washington1 filings